Cargando…
Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
Heterogeneous drug data representation among different druggable genome knowledge resources and datasets delays effective cancer therapeutic target discovery within the broad scientific community. The objective of the present paper is to describe the challenges and lessons learned from our efforts i...
Autores principales: | Jiang, Guoqian, Sohn, Sunghwan, Zimmermann, Michael T., Wang, Chen, Liu, Hongfang, Chute, Christopher G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525232/ https://www.ncbi.nlm.nih.gov/pubmed/26306243 |
Ejemplares similares
-
ADEpedia 2.0: Integration of Normalized Adverse Drug Events (ADEs) Knowledge from the UMLS
por: Jiang, Guoqian, et al.
Publicado: ( 201) -
A Framework of Knowledge Integration and Discovery for Supporting Pharmacogenomics Target Predication of Adverse Drug Events: A Case Study of Drug-Induced Long QT Syndrome
por: Jiang, Guoqian, et al.
Publicado: (2013) -
Mining severe drug-drug interaction adverse events using Semantic Web technologies: a case study
por: Jiang, Guoqian, et al.
Publicado: (2015) -
Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy
por: Wang, Chen, et al.
Publicado: (2015) -
Developing a scalable FHIR-based clinical data normalization pipeline for standardizing and integrating unstructured and structured electronic health record data
por: Hong, Na, et al.
Publicado: (2019)